Hinge Health, Inc. received an updated ownership report from investment entities affiliated with 11.2 Capital and Qian Zhuang regarding holdings of Class A common stock. As of June 30, 2026, the reporting group beneficially owned a total of 2,464,657 shares of Class A common stock, representing 4.0% of the outstanding class, based on 60,859,919 shares outstanding. These holdings consist of 1,911,977 shares held directly by 11.2 Capital I, L.P. and 552,680 shares held directly by 11.2 Capital IVY, LLC. Zhuang, as sole managing member of the relevant general partner and manager entities, has sole voting and dispositive power over the shares held by 11.2 Capital I, 11.2 Capital HH, and 11.2 Capital IVY. The reporting persons state that they own 5 percent or less of this class of securities.
Positive
None.
Negative
None.
Key Figures
Shares held by 11.2 Capital I, L.P.:1,911,977 sharesShares held by 11.2 Capital IVY, LLC:552,680 sharesTotal beneficial ownership:2,464,657 shares+4 more
7 metrics
Shares held by 11.2 Capital I, L.P.1,911,977 sharesClass A common stock beneficially owned as of June 30, 2026
Shares held by 11.2 Capital IVY, LLC552,680 sharesClass A common stock beneficially owned as of June 30, 2026
Total beneficial ownership2,464,657 sharesAggregate Hinge Health Class A shares reported by the group
Ownership percentage4.0%Percent of Hinge Health Class A common stock outstanding
Shares outstanding60,859,919 sharesHinge Health Class A common stock outstanding as of June 30, 2026
11.2 Capital I ownership percentage3.1%Percent of Hinge Health Class A common stock
11.2 Capital IVY ownership percentage0.9%Percent of Hinge Health Class A common stock
Key Terms
beneficially owned, shared voting power, shared dispositive power, sole voting and dispositive power, +1 more
5 terms
beneficially ownedfinancial
"sets forth the aggregate number of shares of Class A common stock of the Issuer beneficially owned"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
shared voting powerfinancial
"Shared Voting Power 1,911,977.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive powerfinancial
"Shared Dispositive Power 1,911,977.00"
sole voting and dispositive powerfinancial
"Zhuang is the sole managing member ... and has sole voting and dispositive power"
percent of classfinancial
"Row 11 of each Reporting Person's cover page ... sets forth the percentages of the Class A common stock"
Percent of class is the portion of a specific category of securities—such as a company’s common shares, preferred shares, or a bond series—that takes part in or approves a corporate action (vote, consent, tender, etc.). Investors watch this number because it reveals how much support or opposition exists within that particular shareholder group; like counting how many members of a club back a proposal, it can determine whether a plan passes or how influence is distributed.
FAQ
How many HNGE shares do the 11.2 Capital entities and Zhuang own?
The reporting persons beneficially own 2,464,657 shares of Hinge Health Class A common stock. This total comes from 1,911,977 shares held by 11.2 Capital I and 552,680 shares held by 11.2 Capital IVY as of June 30, 2026.
What percentage of Hinge Health (HNGE) does 2,464,657 shares represent?
The 2,464,657 shares reported represent 4.0% of Hinge Health’s Class A common stock. This percentage is calculated using 60,859,919 shares outstanding as of June 30, 2026, as disclosed by the company.
How are the HNGE shares split between 11.2 Capital I and 11.2 Capital IVY?
11.2 Capital I, L.P. holds 1,911,977 shares and 11.2 Capital IVY, LLC holds 552,680 shares of Hinge Health Class A stock. Together these positions form the 2,464,657-share beneficial ownership reported for the group.
Does the reporting group own more than 5% of Hinge Health (HNGE)?
No. The reporting persons state that they collectively own 5 percent or less of Hinge Health’s Class A common stock. Their reported beneficial ownership is 4.0% based on 60,859,919 shares outstanding as of June 30, 2026.
Who controls voting and disposition of the reported HNGE shares?
Zhuang is described as having sole voting and dispositive power over shares held by 11.2 Capital I, 11.2 Capital HH, and 11.2 Capital IVY. The entities themselves report shared voting and dispositive power over their respective Hinge Health holdings.
What is the outstanding share count used in this HNGE ownership filing?
The ownership percentages are calculated using 60,859,919 shares of Hinge Health Class A common stock outstanding. This figure comes from the company’s Form 10-Q for the period ended June 30, 2026, filed on August 6, 2026.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 2)
Hinge Health, Inc.
(Name of Issuer)
Class A Common Stock, par value $0.00001 per share
(Title of Class of Securities)
(CUSIP Number)
06/30/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP No.
1
Names of Reporting Persons
11.2 Capital I, L.P.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
1,911,977.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
1,911,977.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
1,911,977.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
3.1 %
12
Type of Reporting Person (See Instructions)
PN
SCHEDULE 13G
CUSIP No.
1
Names of Reporting Persons
11.2 Capital I Partners, LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
1,911,977.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
1,911,977.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
1,911,977.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
3.1 %
12
Type of Reporting Person (See Instructions)
OO
SCHEDULE 13G
CUSIP No.
1
Names of Reporting Persons
11.2 Capital HH, LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
0.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
0.0 %
12
Type of Reporting Person (See Instructions)
OO
SCHEDULE 13G
CUSIP No.
1
Names of Reporting Persons
11.2 Capital IVY, LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
552,680.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
552,680.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
552,680.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
0.9 %
12
Type of Reporting Person (See Instructions)
OO
SCHEDULE 13G
CUSIP No.
1
Names of Reporting Persons
11.2 Capital Ivy Partners, LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
552,680.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
552,680.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
552,680.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
0.9 %
12
Type of Reporting Person (See Instructions)
OO
SCHEDULE 13G
CUSIP No.
1
Names of Reporting Persons
Qian Zhuang
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
2,464,657.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
2,464,657.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
2,464,657.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
4.0 %
12
Type of Reporting Person (See Instructions)
IN
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
Hinge Health, Inc.
(b)
Address of issuer's principal executive offices:
455 Market Street, Suite 700, San Francisco, CA, 94105.
Item 2.
(a)
Name of person filing:
The names of the persons filing this report (collectively, the "Reporting Persons") are:
11.2 Capital I, L.P. ("11.2 Capital I")
11.2 Capital I Partners, LLC ("11.2 Capital I GP")
11.2 Capital HH, LLC ("11.2 Capital HH")
11.2 Capital IVY, LLC ("11.2 Capital IVY")
11.2 Capital Ivy Partners, LLC ("11.2 Capital Mgr")
Qian Zhuang ("Zhuang")
The Reporting Persons expressly disclaim status as a "group" for purposes of this Schedule 13G.
(b)
Address or principal business office or, if none, residence:
c/o 11.2 Capital
1611 Spring Gate Ln, Unit 371763
Las Vegas, Nevada 89134
(c)
Citizenship:
11.2 Capital I Delaware
11.2 Capital I GP Delaware
11.2 Capital HH Delaware
11.2 Capital IVY Delaware
11.2 Capital Mgr Delaware
Zhuang United States
(d)
Title of class of securities:
Class A Common Stock, par value $0.00001 per share
(e)
CUSIP No.:
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
Row 9 of each Reporting Person's cover page to this Schedule 13G sets forth the aggregate number of shares of Class A common stock of the Issuer beneficially owned by such Reporting Person as of June 30, 2026 and is incorporated by reference.
The Reporting Persons' ownership of the Issuer's securities consists of (i) 1,911,977 shares of Class A common stock held directly by 11.2 Capital I; and (ii) 552,680 shares of Class A common stock held directly by 11.2 Capital IVY.
11.2 Capital I GP is the general partner of 11.2 Capital I and 11.2 Capital Mgr is the manager of each of 11.2 Capital HH and 11.2 Capital IVY. Zhuang is the sole managing member of each of 11.2 Capital I GP and 11.2 Capital Mgr and has sole voting and dispositive power over the shares held by each of 11.2 Capital I, 11.2 Capital HH and 11.2 Capital IVY.
(b)
Percent of class:
Row 11 of each Reporting Person's cover page to this Schedule 13G sets forth the percentages of the Class A common stock of the Issuer beneficially owned by such Reporting Person as of June 30, 2026 and is incorporated by reference. The percentage set forth in each row 11 is based upon 60,859,919 shares of Class A common stock outstanding as of June 30, 2026, as reported in the Issuer's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission (the "SEC") on August 6, 2026.
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
Row 5 of each Reporting Person's cover page to this Schedule 13G sets forth the sole power to vote or to direct the vote of securities of the Issuer beneficially owned by such Reporting Person as of June 30, 2026 and is incorporated by reference.
(ii) Shared power to vote or to direct the vote:
Row 6 of each Reporting Person's cover page to this Schedule 13G sets forth the shared power to vote or to direct the vote of securities of the Issuer beneficially owned by such Reporting Person as of June 30, 2026 and is incorporated by reference.
(iii) Sole power to dispose or to direct the disposition of:
Row 7 of each Reporting Person's cover page to this Schedule 13G sets forth the sole power to dispose or to direct the disposition of securities of the Issuer beneficially owned by such Reporting Person as of June 30, 2026 and is incorporated by reference.
(iv) Shared power to dispose or to direct the disposition of:
Row 8 of each Reporting Person's cover page to this Schedule 13G sets forth the shared power to dispose or to direct the disposition of securities of the Issuer beneficially owned by such Reporting Person as of June 30, 2026 and is incorporated by reference.
Item 5.
Ownership of 5 Percent or Less of a Class.
Ownership of 5 percent or less of a class
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
Not Applicable
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
Not Applicable
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
11.2 Capital I, L.P.
Signature:
/s/ Shelley Zhuang
Name/Title:
By 11.2 Capital I Partners, LLC, its General Partner, By Shelley Zhuang, Managing Member
Date:
08/13/2026
11.2 Capital I Partners, LLC
Signature:
/s/ Shelley Zhuang
Name/Title:
By Shelley Zhuang, Managing Member
Date:
08/13/2026
11.2 Capital HH, LLC
Signature:
/s/ Shelley Zhuang
Name/Title:
By 11.2 Capital Ivy Partners, LLC, its Manager, By Shelley Zhuang, Managing Member
Date:
08/13/2026
11.2 Capital IVY, LLC
Signature:
/s/ Shelley Zhuang
Name/Title:
By 11.2 Capital Ivy Partners, LLC, its Manager, By Shelley Zhuang, Managing Member
Date:
08/13/2026
11.2 Capital Ivy Partners, LLC
Signature:
/s/ Shelley Zhuang
Name/Title:
By Shelley Zhuang, Managing Member
Date:
08/13/2026
Qian Zhuang
Signature:
/s/ Shelley Zhuang
Name/Title:
Shelley Zhuang
Date:
08/13/2026
Exhibit Information
Exhibit 99.1 Joint Filing Agreement (incorporated by reference to Exhibit 99.1 to the Reporting Persons' Schedule 13G filed with the SEC on August 14, 2025)
